Boston Scientific Corp
BSXNYSECIK 885725HealthcareFiscal year ends Dec 31
Reports and events: 394 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0706:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-26-000064 |
| 2026-09-2306:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000885725-26-000061 |
| 2026-09-0806:15 ET | 8-K | 1.05 Material cybersecurity incident | 0000885725-26-000059 |
| 2026-08-2606:06 ET | 8-K | 8.01 Other events | 0000885725-26-000056 |
| 2026-08-0306:32 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000885725-26-000053 |
| 2026-07-2906:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-26-000051 |
| 2026-07-2716:06 ET | 8-K | 2.05 Exit or disposal costs | 0000885725-26-000049 |
| 2026-05-1807:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-26-000042 |
| 2026-05-1807:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-26-000041 |
| 2026-05-0516:47 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000885725-26-000036 |
| 2026-05-0106:25 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000885725-26-000033 |
| 2026-04-2206:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-26-000031 |
| 2026-03-3006:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-26-000029 |
| 2026-03-1816:56 ET | DEF 14A | Proxy statementPeriod 2026-03-18 | 0000885725-26-000025 |
| 2026-02-2617:11 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000885725-26-000017 |
| 2026-02-2316:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-26-000013 |
| 2026-02-1716:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000885725-26-000010 |
| 2026-02-0516:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000885725-26-000008 |
| 2026-02-0406:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-26-000006 |
| 2026-01-1517:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000947871-26-000037 |
| 2026-01-1507:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-26-000034 |
| 2025-11-1916:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885725-25-000052 |
| 2025-11-0306:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000885725-25-000050 |
| 2025-10-2316:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000885725-25-000048 |
| 2025-10-2206:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-25-000046 |
| 2025-09-0416:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000885725-25-000043 |
| 2025-08-0106:32 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000885725-25-000041 |
| 2025-07-2306:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-25-000039 |
| 2025-05-2807:45 ET | 8-K | 8.01 Other events | 0000885725-25-000033 |
| 2025-05-0616:26 ET | 8-K | 5.07 Shareholder vote results | 0000885725-25-000028 |
| 2025-05-0106:31 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000885725-25-000026 |
| 2025-04-2306:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-25-000024 |
| 2025-04-2306:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-25-000023 |
| 2025-03-1916:27 ET | DEF 14A | Proxy statementPeriod 2025-03-19 | 0000885725-25-000017 |
| 2025-02-2616:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-25-000013 |
| 2025-02-1816:13 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000885725-25-000011 |
| 2025-02-1216:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000885725-25-000009 |
| 2025-02-0506:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-25-000007 |
| 2025-01-1616:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-25-000003 |
| 2024-11-2216:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885725-24-000081 |
| 2024-11-1516:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-24-000078 |
| 2024-11-0707:00 ET | 8-K | 7.01 Regulation FD disclosure | 0000885725-24-000075 |
| 2024-11-0106:33 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000885725-24-000073 |
| 2024-10-2306:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-24-000070 |
| 2024-08-0116:16 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000885725-24-000068 |
| 2024-07-3016:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885725-24-000063 |
| 2024-07-2406:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-24-000060 |
| 2024-05-1016:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-24-000050 |
| 2024-05-0616:13 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000885725-24-000048 |
| 2024-05-0116:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000885725-24-000046 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 06:35 ET. Listed shows no prices and gives no investment advice.